Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1Sarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Familial ependymoma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Astrocytoma 1AIDS-related Kaposi sarcoma 1

Interventions

Paclitaxel 2Nelfinavir 2nirogacestat 1liposomal doxorubicin 1ixazomib 1emvododstat 1Valproic Acid 1Sirolimus 1Semaxinib 1Saquinavir 1Ritonavir 1Propranolol 1Polymerase Chain Reaction 1Palliative Care 1Nutritional Support 1Indinavir 1Immunohistochemistry 1Imatinib Mesylate 1Gene Expression Profiling 1Etoposide 1Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1Daunorubicin 1Celecoxib 1Biopsy 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sarcoma, Kaposi × Semaxinib × Clear all
NCT00005042 2014-08-29

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

AIDS Malignancy Consortium

Phase 2 Completed
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡